394 related articles for article (PubMed ID: 20059332)
21. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.
Vayne C; Guery EA; Kizlik-Masson C; Rollin J; Bauters A; Gruel Y; Pouplard C
Br J Haematol; 2017 Dec; 179(5):811-819. PubMed ID: 29048130
[TBL] [Abstract][Full Text] [Related]
22. [Heparin-induced thrombocytopenia (HIT): pathogenesis, laboratory test, and treatment].
Matsuo T; Wanaka K; Asada R
Rinsho Byori; 2005 Jul; 53(7):622-9. PubMed ID: 16104531
[TBL] [Abstract][Full Text] [Related]
23. Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.
Ortel TL
Hematology Am Soc Hematol Educ Program; 2009; ():225-32. PubMed ID: 20008202
[TBL] [Abstract][Full Text] [Related]
24. Cardiology for the primary care provider: heparin-induced thrombocytopenia.
Benton RE; Gersh BJ
South Med J; 1998 Feb; 91(2):133-7. PubMed ID: 9496863
[TBL] [Abstract][Full Text] [Related]
25. Recognition and management of heparin-induced thrombocytopenia (HIT) and thrombosis.
Alving BM; Krishnamurti C
Semin Thromb Hemost; 1997; 23(6):569-74. PubMed ID: 9469632
[TBL] [Abstract][Full Text] [Related]
26. [Heparin-induced trombocytopenia: pathogenesis, clinical manifestations and management in hemodialysis].
Esposito P; Libetta C; Borettaz I; Barone M; Canevari M; Martinelli C; Montagna F; Romeo S; Margiotta E; Calatroni M; La Porta E; Dal Canton A
G Ital Nefrol; 2014; 31(3):. PubMed ID: 25030007
[TBL] [Abstract][Full Text] [Related]
27. Testing for heparin-induced thrombocytopenia antibodies.
Warkentin TE; Sheppard JA
Transfus Med Rev; 2006 Oct; 20(4):259-72. PubMed ID: 17008164
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis and management of heparin-induced thrombocytopenia.
de Maistre E; Gruel Y; Lasne D
Can J Anaesth; 2006 Jun; 53(6 Suppl):S123-34. PubMed ID: 16766786
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G
Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902
[TBL] [Abstract][Full Text] [Related]
30. Heparin-induced thrombocytopenia: a ten-year retrospective.
Warkentin TE
Annu Rev Med; 1999; 50():129-47. PubMed ID: 10073268
[TBL] [Abstract][Full Text] [Related]
31. Heparin-induced thrombocytopenia.
Greinacher A; Fürll B; Selleng S
Methods Mol Biol; 2013; 992():301-18. PubMed ID: 23546723
[TBL] [Abstract][Full Text] [Related]
32. Anti-heparin/platelet factor 4 antibody optical density values and the confirmatory procedure in the diagnosis of heparin-induced thrombocytopenia.
Whitlatch NL; Perry SL; Ortel TL
Thromb Haemost; 2008 Oct; 100(4):678-84. PubMed ID: 18841292
[TBL] [Abstract][Full Text] [Related]
33. Heparin induced thrombocytopenia: position paper from the Italian Society on Thrombosis and Haemostasis (SISET).
Marcucci R; Berteotti M; Gori AM; Giusti B; Rogolino AA; Sticchi E; Liotta AA; Ageno W; De Candia E; Gresele P; Marchetti M; Marietta M; Tripodi A
Blood Transfus; 2021 Jan; 19(1):14-23. PubMed ID: 33370230
[TBL] [Abstract][Full Text] [Related]
34. [Heparin-induced thrombocytopenia. New therapeutical options].
Seculini Patiño CE; Tabares AH
Medicina (B Aires); 2016; 76(4):230-4. PubMed ID: 27576282
[TBL] [Abstract][Full Text] [Related]
35. Overdiagnosis of heparin-induced thrombocytopenia in surgical ICU patients.
Berry C; Tcherniantchouk O; Ley EJ; Salim A; Mirocha J; Martin-Stone S; Stolpner D; Margulies DR
J Am Coll Surg; 2011 Jul; 213(1):10-7; discussion 17-8. PubMed ID: 21531584
[TBL] [Abstract][Full Text] [Related]
36. Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder.
Venier LM; Clerici B; Bissola AL; Modi D; Jevtic SD; Radford M; Mahamad S; Nazy I; Arnold DM
Int J Hematol; 2023 Mar; 117(3):341-348. PubMed ID: 36574172
[TBL] [Abstract][Full Text] [Related]
37. Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia.
Warkentin TE; Greinacher A
Thromb Res; 2021 Aug; 204():40-51. PubMed ID: 34144250
[TBL] [Abstract][Full Text] [Related]
38. Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study.
Linkins LA; Bates SM; Lee AY; Heddle NM; Wang G; Warkentin TE
Blood; 2015 Jul; 126(5):597-603. PubMed ID: 25926600
[TBL] [Abstract][Full Text] [Related]
39. [Heparin-induced thrombocytopenia: implictions for cardiologist].
Mattioli AV
G Ital Cardiol (Rome); 2006 Oct; 7(10):675-83. PubMed ID: 17171989
[TBL] [Abstract][Full Text] [Related]
40. Improving clinical interpretation of the anti-platelet factor 4/heparin enzyme-linked immunosorbent assay for the diagnosis of heparin-induced thrombocytopenia through the use of receiver operating characteristic analysis, stratum-specific likelihood ratios, and Bayes theorem.
Raschke RA; Curry SC; Warkentin TE; Gerkin RD
Chest; 2013 Oct; 144(4):1269-1275. PubMed ID: 23703622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
